Cargando…
Dronedarone-induced Phototoxicity in a Patient with Atrial Fibrillation
Dronedarone is a class III antiarrhythmic agent and a potent blocker of multiple intracardiac ion channels with many electrophysical properties common with amiodarone. Oral dronedarone, 400 mg twice daily, is approved for the maintenance of normal sinus rhythm in patients with a history of atrial fi...
Autores principales: | Datar, Praveen, Kafle, Paritosh, Schmidt, Frances M, Bhattarai, Bikash, Mukhtar, Osama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822562/ https://www.ncbi.nlm.nih.gov/pubmed/31700760 http://dx.doi.org/10.7759/cureus.5731 |
Ejemplares similares
-
Correction of Hypernatremia Due to Pure Dehydration Could Be a Potential Risk Factor for Transient Atrial Fibrillation
por: Timilsina, Sanjay, et al.
Publicado: (2019) -
Dronedarone in the management of atrial fibrillation
por: Saleem, TS Mohamed, et al.
Publicado: (2010) -
Management of atrial fibrillation: focus on the role of dronedarone
por: Cheng, Judy WM
Publicado: (2011) -
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010) -
Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
por: Christiansen, Christine Benn, et al.
Publicado: (2010)